MedPath

Clinical Evaluation of Four Aesthetic Restorations in Non-carious Cervical Lesions

Not Applicable
Withdrawn
Conditions
Noncarious Cervical Lesions
Interventions
Other: NexComp Flow
Other: 3M Espe Bulk-fill
Other: Clearfil Majesty Esthetic
Other: EQUIA Forte Fil
Registration Number
NCT04261140
Lead Sponsor
Recep Tayyip Erdogan University Training and Research Hospital
Brief Summary

To compare the clinical performance of high-viscosity glass ionomer, flowable composite, bulkfill composite and nanohybrid composite restorations in non-carious cervical lesions (NCCLs).

Detailed Description

One hundred fourty NCCLs were randomised into four groups according to a split-mouth design. Clinical evaluations will be performed after 1 week, 3 months, 6 months, using FDI (World Dental Federation) criteria.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • had at least four non-carious symmetrical cervical lesions,
  • had permanent dentition and were older than 20 years old,
  • had cervical margins in dentin
Exclusion Criteria
  • periodontal disease
  • pregnant or breastfeeding
  • being under orthodontic therapy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
flowable compositeNexComp Flow-
bulkfill composite3M Espe Bulk-fill-
nanohybrid compositeClearfil Majesty Esthetic-
High-viscosity glass ionomerEQUIA Forte Fil-
Primary Outcome Measures
NameTimeMethod
evaluation of restoration on cervical lesions6 months

According to FDI criteria (aesthetic, biological and fuctional) score 1, clinically very good; score 2, clinically good; score 3, clinically sufficient; score 4, clinically unsatisfactory; score 5, clinically poor. Scores 1-3 show clinically acceptable restoration, while scores 4 and 5 indicate failure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Recep Tayyip Erdogan University Dentistry Faculty

🇹🇷

Rize, Turkey

© Copyright 2025. All Rights Reserved by MedPath